Immunophotonics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
Phase 1
Active, not recruiting
- Conditions
- Metastatic Solid TumorColon CancerNonsmall Cell Lung CancerSoft Tissue Sarcoma
- Interventions
- Drug: 1.0% IP-001 for Injection
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Immunophotonics, Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT05688280
- Locations
- 🇺🇸
Miami Cardiac & Vascular Institute, Coral Gables, Florida, United States
🇺🇸University of Louisville Physicians, PSC, Louisville, Kentucky, United States
🇺🇸Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
© Copyright 2025. All Rights Reserved by MedPath